Business article - February 29, 2024
Center for Translational Research launches CTC Netherlands
Center for Translational Research (CTR) expands its portfolio of life science service companies through the establishment of CTC Netherlands BV. CTC Netherlands BV is CTR group’s first company outside of Sweden. The new company will operate a clinical research unit that specializes in early phase patient research and healthy volunteer studies that require invasive procedures. […]
Agreement - February 13, 2024
Sobi and Handok establish joint venture for rare disease business
The joint venture will commercialize and distribute selected Sobi medicines in South Korea. The joint venture, due for incorporation in the first half of this year, is expected to enhance the Sobi and Handok collaboration, they state. Strengthening their position in the rare disease business, Handok and Sobi aim to develop, commercialize and distribute Sobi’s […]
MedTech Business - January 29, 2024
Capitainer opens new qDBS microsampling laboratory in US
Capitainer has announced the opening of its new US laboratory, miQro Lab Solutions, in Warwick, Rhode Island. This step reflects the company’s ambition to integrating its advanced self-sampling solutions into the U.S. healthcare system more rapidly, it states. Initially, the new miQro Lab Solutions laboratory will focus on clinical lab services, specializing in lead (Pb) […]
MedTech Business - January 26, 2024
Getinge inaugurates its Global Centre of Excellence for Chemistry
The new centre, which also becomes the UK headquarters, bring together the company’s chemistry and instrument decontamination business. It will be inaugurated on January 31 and is located in the industrial & logistics park St. Modwen Park Derby. During the opening Getinge will showcase the 79’000 sq/ft production, warehouse, laboratory, showroom, training area and office […]
Collaboration - January 25, 2024
Sigrid Therapeutics collaborates with Cencora
Sigrid Therapeutics has entered into an agreement with Cencora aimed at accelerating the commercialization of its SiPore technology. SiPore21 is currently undergoing SHINE clinical trials as an innovative medical device designed for sustained blood sugar and weight control. Administered orally, SiPore21 utilizes a mesoporous silica mineral to prevent digestive enzymes from breaking down carbohydrates and […]
Biotech Business - January 8, 2024
Anocca receives certificate of GMP compliance for its in-house cell therapy manufacturing facility
The manufacturing license paves the way for Anocca’s near-term path to the clinic and long-term strategy to advance franchises of precision targeted cell therapies for different cancers and covering diverse patient populations. Anocca has built validated asset franchises against valuable cancer targets including KRAS, PRAME and MAGE, with more than 40 preclinical assets in the […]
